These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23392639)

  • 21. Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
    Paas-Rozner M; Dayan M; Paas Y; Changeux JP; Wirguin I; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2168-73. PubMed ID: 10681457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.
    Tüzün E; Scott BG; Goluszko E; Higgs S; Christadoss P
    J Immunol; 2003 Oct; 171(7):3847-54. PubMed ID: 14500686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel complement inhibitor limits severity of experimentally myasthenia gravis.
    Soltys J; Kusner LL; Young A; Richmonds C; Hatala D; Gong B; Shanmugavel V; Kaminski HJ
    Ann Neurol; 2009 Jan; 65(1):67-75. PubMed ID: 19194881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
    Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
    Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.
    Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L
    Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.
    Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L
    Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis.
    Allman W; Saini SS; Tuzun E; Christadoss P
    Cell Immunol; 2011; 271(2):292-8. PubMed ID: 21861992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in acetylcholinesterase in experimental autoimmune myasthenia gravis and in response to treatment with a specific antisense.
    Blotnick E; Hamra-Amitai Y; Wald C; Brenner T; Anglister L
    Eur J Neurosci; 2012 Oct; 36(8):3077-85. PubMed ID: 22805122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
    Lennon VA; Seybold ME; Lindstrom JM; Cochrane C; Ulevitch R
    J Exp Med; 1978 Apr; 147(4):973-83. PubMed ID: 206648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.
    Meinen S; Lin S; Rüegg MA; Punga AR
    PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice.
    Theissen L; Schroeter CB; Huntemann N; Räuber S; Dobelmann V; Cengiz D; Herrmann A; Koch-Hölsken K; Gerdes N; Hu H; Mourikis P; Polzin A; Kelm M; Hartung HP; Meuth SG; Nelke C; Ruck T
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice.
    Jermy A; Beeson D; Vincent A
    Eur J Immunol; 1993 Apr; 23(4):973-6. PubMed ID: 8458383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.